欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1921/005
药品名称
Flutiform K-haler
活性成分
fluticasone propionate 125.0 µg
formoterol dihydrate 5.0 µg
剂型
Pressurised inhalation, suspension
上市许可持有人
Mundipharma AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Hungary (HU)
Czechia (CZ)
United Kingdom (Northern Ireland) (XI)
Flutiform K-haler 125 microgram / 5 microgram
Norway (NO)
Bulgaria (BG)
Italy (IT)
Slovakia (SK)
许可日期
2017/10/03
最近更新日期
2024/08/19
药物ATC编码
R03AK07 formoterol and budesonide
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
SE_H_1921_005_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1921_005_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase